Terminology Service for NFDI4Health

Irinotecan/Panitumumab/Vemurafenib Regimen

Go to external page http://purl.obolibrary.org/obo/NCIT_C153482


A chemoimmunotherapy regimen consisting of irinotecan, panitumumab and vemurafenib that can be used for the treatment of colon cancer. [ ]

Term info

Label

Irinotecan/Panitumumab/Vemurafenib Regimen

Synonyms
  • Irinotecan + Panitumumab + Vemurafenib
  • Irinotecan + Panitumumab + Vemurafenib Regimen
  • Irinotecan + Panitumumab Regimen
  • Irinotecan-Panitumumab-Vemurafenib
  • Irinotecan-Panitumumab-Vemurafenib Regimen
  • Irinotecan/Panitumumab/Vemurafenib
  • Irinotecan/Panitumumab/Vemurafenib Regimen
Subsets

NCIT_C160952, NCIT_C160950

DesignNote

NCCN guidelines 2018

NCI META CUI

CL554977

Preferred Name

Irinotecan/Panitumumab/Vemurafenib Regimen

Semantic Type

Therapeutic or Preventive Procedure

code

C153482